Recently, an orally active, small-molecule TNF inhibitor (TNF-inhibitory molecule 1, TIM1) was found to be effective for treatment of rheumatoid arthritis and other TNF-dependent systemic disorders of inflammation (Javaid et al. 2022), and TIM1 seems to be useful in cancer treatment. The gene discussed is TNF; the disease is cancer.